Options for medical treatment of myomas

Obstetrics and Gynecology Clinics of North America

Volumn 33, Issue 1, 2006, Pages 97-113

  Rackow, Beth W ^a   Arici, Aydin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; AROMATASE INHIBITOR; ASOPRISNIL; CETRORELIX; DANAZOL; ESTROGEN; FADROZOLE; GANIRELIX; GESTAGEN; GESTRINONE; GONADORELIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LEUPRORELIN; LEVONORGESTREL; LIVER ENZYME; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; PIRFENIDONE; PROGESTERONE RECEPTOR MODULATOR; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ABDOMINAL PAIN; ACNE; AMENORRHEA; ANEMIA; ARTHRALGIA; BONE DEMINERALIZATION; BREAST DISEASE; CANCER; CANCER THERAPY; CHRONIC PAIN; CLINICAL TRIAL; DEPRESSION; DIZZINESS; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; DRUG TOLERABILITY; DYSMENORRHEA; DYSPAREUNIA; EDEMA; ENDOCRINE DISEASE; ENDOMETRIAL DISEASE; ENDOMETRIUM HYPERPLASIA; ESTROGEN BLOOD LEVEL; ESTROGEN SYNTHESIS; FEMALE; FLUID RETENTION; HEADACHE; HIRSUTISM; HOARSENESS; HOT FLUSH; HUMAN; HYSTERECTOMY; INTRAUTERINE CONTRACEPTIVE DEVICE; LARYNX DISORDER; LIBIDO DISORDER; LIVER CELL DAMAGE; LOW DRUG DOSE; MASTALGIA; MENORRHAGIA; MENSTRUAL IRREGULARITY; MENSTRUATION; MUSCLE CRAMP; MYALGIA; MYOMECTOMY; NAUSEA; OILY SKIN; OSTEOPOROSIS; OVARY CYST; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEBORRHEA; SIDE EFFECT; SPONTANEOUS ABORTION; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; UTERUS BLEEDING; UTERUS MYOMA; VAGINAL DRYNESS; VASOMOTOR DISORDER; WEIGHT GAIN;

CLINICAL TRIALS; FEMALE; HORMONE ANTAGONISTS; HORMONES; HUMANS; LEIOMYOMA; UTERINE NEOPLASMS;

EID: 33644508343     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2005.12.014     Document Type: Review

References (69)

1. V.C. Buttram Jr, and R.C. Reiter Uterine leiomyomata: etiology, symptomatology, and management Fertil Steril 36 4 1981 433 445
2. I. Manyonda, E. Sinthamoney, and A.M. Belli Controversies and challenges in the modern management of uterine fibroids BJOG 111 2 2004 95 102
3. D.L. Olive, S.R. Lindheim, and E.A. Pritts Non-surgical management of leiomyoma: impact on fertility Curr Opin Obstet Gynecol 16 3 2004 239 243
4. E.E. Wallach, and N.F. Vlahos Uterine myomas: an overview of development, clinical features, and management Obstet Gynecol 104 2 2004 393 406
5. K. Chwalisz, D. DeManno, and R. Garg Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leiomyomata Semin Reprod Med 22 2 2004 113 119
6. E.A. Stewart Uterine fibroids Lancet 357 9252 2001 293 298
7. The Practice Committee of the American Society for Reproductive Medicine Myomas and reproductive function Fertil Steril 82 Suppl 1 2004 S111 S116
8. H. Keshavarz, S.D. Hillis, and B.A. Kieke Hysterectomy surveillance-United States, 1994-1999 MMWR Surveill Summ 51 SS-5 2002 1 8
9. V. De Leo, G. Morgante, and A. La Marca A benefit-risk assessment of medical treatment for uterine leiomyomas Drug Saf 25 11 2002 759 779
10. J.D. Cook, and C.L. Walker Treatment strategies for uterine leiomyoma: the role of hormonal modulation Semin Reprod Med 22 2 2004 105 111
11. L.M. Marshall, D. Spiegelman, and M.B. Goldman A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata Fertil Steril 70 3 1998 432 439
12. K. Englund, A. Blanck, and I. Gustavsson Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment J Clin Endocrinol Metab 83 11 1998 4092 4096
13. M. Nisolle, S. Gillerot, and F. Casanas-Roux Immunohistochemical study of the proliferation index, oestrogen receptors and progesterone receptors A and B in leiomyomata and normal myometrium during the menstrual cycle and under gonadotrophin-releasing hormone agonist therapy Hum Reprod 14 11 1999 2844 2850
14. N. Chegini, C. Ma, and X.M. Tang Effects of GnRH analogues, 'add-back' steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression Mol Hum Reprod 8 12 2002 1071 1078
15. K. Kawaguchi, S. Fujii, and I. Konishi Mitotic activity in uterine leiomyomas during the menstrual cycle Am J Obstet Gynecol 160 3 1989 637 641
16. M.S. Rein, R.L. Barbieri, and A.J. Friedman Progesterone: a critical role in the pathogenesis of uterine myomas Am J Obstet Gynecol 172 1 Pt 1 1995 14 18
17. A.J. Tiltman The effect of progestins on the mitotic activity of uterine fibromyomas Int J Gynecol Pathol 4 2 1985 89 96
18. M. Shozu, K. Murakami, and M. Inoue Aromatase and leiomyoma of the uterus Semin Reprod Med 22 1 2004 51 60
19. M. Shozu, H. Sumitani, and T. Segawa Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate J Clin Endocrinol Metab 86 11 2001 5405 5411
20. L. Deligdish, and M. Loewenthal Endometrial changes associated with myomata of the uterus J Clin Pathol 23 8 1970 676 680
21. G. Farrer-Brown, J.O. Beilby, and M.H. Tarbit Venous changes in the endometrium of myomatous uteri Obstet Gynecol 38 5 1971 743 751
22. T. Maruo, H. Matsuo, and Y. Shimomura Effects of progesterone on growth factor expression in human uterine leiomyoma Steroids 68 10-13 2003 817 824
23. R.A. Nowak Fibroids: pathophysiology and current medical treatment Baillieres Best Pract Res Clin Obstet Gynaecol 13 2 1999 223 238
24. E.A. Stewart Epidemiology, pathogenesis, diagnosis, and natural history of uterine leiomyomas B.D. Rose UpToDate 2005 UpToDate Waltham, Massachusetts
25. E.A. Stewart, and R.A. Nowak Leiomyoma-related bleeding: a classic hypothesis updated for the molecular era Hum Reprod Update 2 4 1996 295 306
26. E.A. Stewart Treatment of uterine leiomyomas B.D. Rose UpToDate 2005 UpToDate Waltham, Massachusetts
27. A.J. Friedman, and P.P. Thomas Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas? Obstet Gynecol 85 4 1995 631 635
28. S. Venkatachalam, J.S. Bagratee, and J. Moodley Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study J Obstet Gynaecol 24 7 2004 798 800
29. M. Harrison-Woolrych, and R. Robinson Fibroid growth in response to high-dose progestogen Fertil Steril 64 1 1995 191 192
30. W.T. Mixson, and D.O. Hammond Response of fibromyomas to a progestin Am J Obstet Gynecol 82 1961 754 760
31. B.R. Carr, P.B. Marshburn, and P.T. Weatherall An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial J Clin Endocrinol Metab 76 5 1993 1217 1223
32. A.J. Friedman, M. Daly, and M. Juneau-Norcross Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years Hum Reprod 9 9 1994 1618 1625
33. A.J. Friedman, M. Daly, and M. Juneau-Norcross A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri J Clin Endocrinol Metab 76 6 1993 1439 1445
34. A. Golan GnRH analogues in the treatment of uterine fibroids Hum Reprod 11 Suppl 3 1996 33 41
35. W.D. Schlaff, E.A. Zerhouni, and J.A. Huth A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata Obstet Gynecol 74 6 1989 856 862
36. A. Lethaby, B. Vollenhoven, and M. Sowter Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review BJOG 109 10 2002 1097 1108
37. P. Vercellini, L. Trespidi, and B. Zaina Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial Fertil Steril 79 6 2003 1390 1395
38. T.G. Stovall, O. Muneyyirci-Delale, and R.L. Summitt Jr GnRH agonist and iron versus placebo and iron in the anemic patient before surgery for leiomyomas: a randomized controlled trial. Leuprolide Acetate Study Group Obstet Gynecol 86 1 1995 65 71
39. M.E. Coccia, C. Comparetto, and G.L. Bracco GnRH antagonists Eur J Obstet Gynecol Reprod Biol 115 Suppl 1 2004 S44 S56
40. R.E. Felberbaum, U. Germer, and M. Ludwig Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin-releasing hormone antagonist Cetrorelix Hum Reprod 13 6 1998 1660 1668
41. P.A. Flierman, J.J. Oberye, and V.P. van der Hulst Rapid reduction of leiomyoma volume during treatment with the GnRH antagonist ganirelix BJOG 112 5 2005 638 642
42. D. Gonzalez-Barcena, R.B. Alvarez, and E.P. Ochoa Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix Hum Reprod 12 9 1997 2028 2035
43. O. Sadan, S. Ginath, and D. Sofer The role of tamoxifen in the treatment of symptomatic uterine leiomyomata-a pilot study Eur J Obstet Gynecol Reprod Biol 96 2 2001 183 186
44. V.L. Baker, M. Draper, and S. Paul Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles J Clin Endocrinol Metab 83 1 1998 6 13
45. S. Palomba, A. Sammartino, and C. Di Carlo Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women Fertil Steril 76 1 2001 38 43
46. S. Palomba, F. Orio Jr, and M. Morelli Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study J Clin Endocrinol Metab 87 8 2002 3603 3608
47. S. Jirecek, A. Lee, and I. Pavo Raloxifene prevents the growth of uterine leiomyomas in premenopausal women Fertil Steril 81 1 2004 132 136
48. S. Palomba, T. Russo, and F. Orio Jr Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas: a prospective, randomized, single-blind, placebo-controlled clinical trial Hum Reprod 17 12 2002 3213 3219
49. S. Palomba, F. Orio Jr, and T. Russo Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas Hum Reprod 19 6 2004 1308 1314
50. M. Shozu, K. Murakami, and T. Segawa Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor Fertil Steril 79 3 2003 628 631
51. T.J. Iveson, I.E. Smith, and J. Ahern Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in postmenopausal patients with advanced breast cancer Cancer Res 53 2 1993 266 270
52. J. Steinauer, E.A. Pritts, and R. Jackson Systematic review of mifepristone for the treatment of uterine leiomyomata Obstet Gynecol 103 6 2004 1331 1336
53. A.A. Murphy, L.M. Kettel, and A.J. Morales Regression of uterine leiomyomata in response to the antiprogesterone RU 486 J Clin Endocrinol Metab 76 2 1993 513 517
54. A.A. Murphy, A.J. Morales, and L.M. Kettel Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect Fertil Steril 64 1 1995 187 190
55. S.H. Eisinger, S. Meldrum, and K. Fiscella Low-dose mifepristone for uterine leiomyomata Obstet Gynecol 101 2 2003 243 250
56. K. Chwalisz, M.C. Perez, and D. Demanno Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis Endocr Rev 26 3 2005 423 438
57. Chwalisz K., Parker R.L., Williamson S., et al. Treatment of uterine leiomyomas with the novel selective progesterone receptor modulator (SPRM). J Soc Gynecol Investig 2003;10(2 Suppl):Abstract 301A
58. V. De Leo, A. la Marca, and G. Morgante Short-term treatment of uterine fibromyomas with danazol Gynecol Obstet Invest 47 4 1999 258 262
59. A. La Marca, M.C. Musacchio, and G. Morgante Hemodynamic effect of danazol therapy in women with uterine leiomyomata Fertil Steril 79 5 2003 1240 1242
60. E.M. Coutinho, G.A. Boulanger, and M.T. Goncalves Regression of uterine leiomyomas after treatment with gestrinone, an antiestrogen, antiprogesterone Am J Obstet Gynecol 155 4 1986 761 767
61. E.M. Coutinho, and M.T. Goncalves Long-term treatment of leiomyomas with gestrinone Fertil Steril 51 6 1989 939 946
62. R. Hurskainen, and J. Paavonen Levonorgestrel-releasing intrauterine system in the treatment of heavy menstrual bleeding Curr Opin Obstet Gynecol 16 6 2004 487 490
63. A. Stewart, C. Cummins, and L. Gold The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review BJOG 108 1 2001 74 86
64. V. Grigorieva, M. Chen-Mok, and M. Tarasova Use of a levonorgestrel- releasing intrauterine system to treat bleeding related to uterine leiomyomas Fertil Steril 79 5 2003 1194 1198
65. P. Inki, R. Hurskainen, and P. Palo Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy Ultrasound Obstet Gynecol 20 4 2002 381 385
66. E.A. Stewart, and R.A. Nowak New concepts in the treatment of uterine leiomyomas Obstet Gynecol 92 4 Pt 1 1998 624 627
67. S.L. Young, A. Al-Hendy, and J.A. Copland Potential nonhormonal therapeutics for medical treatment of leiomyomas Semin Reprod Med 22 2 2004 121 130
68. B.S. Lee, S.B. Margolin, and R.A. Nowak Pirfenidone: a novel pharmacological agent that inhibits leiomyoma cell proliferation and collagen production J Clin Endocrinol Metab 83 1 1998 219 223
69. E.R. Myers, M.D. Barber, and T. Gustilo-Ashby Management of uterine leiomyomata: what do we really know? Obstet Gynecol 100 1 2002 8 17